Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway
Zhiwei Zhang(Second Hospital of Tianjin Medical University), Tong Liu(Second Hospital of Tianjin Medical University), Jianping Zhao(Xinjiang University), Wen Shi(Shanghai Jiao Tong University), Yajuan Yang(Second Hospital of Tianjin Medical University), Xinghua Wang(Second Hospital of Tianjin Medical University), Xiaowei Zhang(Lanzhou University Second Hospital), Xue Liang(Chongqing Normal University), Jian Li(National Clinical Research), Guangping Li(Qingdao University), Ning Jiang(Tianjin University of Sport), Yungang Zhao(Tianjin University of Sport), Lei Meng(Shandong University of Technology), Ya Suo(Second Hospital of Tianjin Medical University), Gary Tse(Observational & Pragmatic Research Institute), Mengqi Gong(Central South University), Jiuchun Qiu(Second Hospital of Tianjin Medical University)
Cited by 79
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
|Journal of Allergy and Clinical Immunology|2020|2.4k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
|Signal Transduction and Targeted Therapy|2022|1.5k